Pathological feature | Â | Number of patients (%) | P-value |
---|---|---|---|
LEP(-2548) G/A | GG | GA + AA | Â |
Tumor size | |||
T1-T2 | 82 (42.05) | 113 (57.95) | 0.05 |
T3-T4 | 21 (26.92) | 57 (73.08) | Â |
Histological grade | |||
1–2 | 68 (39.08) | 106 (60.92) | 0.3 |
3 | 28 (32.56) | 58 (67.44) | Â |
Lymph node metastases | |||
Negative | 64 (42.38) | 87 (57.62) | 0.13 |
Positive | 51 (34.00) | 99 (66.00) | Â |
Hormone receptor status | |||
Negative | 34 (38.20) | 55 (61.80) | 0.36 |
Positive | 77 (44.00) | 98 (56.00) | Â |
LEPR Q223R | QQ + RR | Â | |
Tumor size | |||
T1-T2 | 56 (29.17) | 136 (70.83) | 0.57 |
T3-T4 | 27 (32.53) | 56 (67.47) | Â |
Histological grade | |||
1–2 | 58 (32.95) | 118 (67.05) | 0.19 |
3 | 21 (25.00) | 63 (75.00) | Â |
Lymph node metastases | |||
Negative | 55 (36.67) | 95 (63.33) | 0.07 |
Positive | 41 (27.15) | 110 (72.85) | Â |
Hormone receptor status | |||
Negative | 40 (41.53) | 49 (58.47) | 0.57 |
Positive | 85 (34.33) | 90 (65.67) | Â |